⌘K

Login Start Free

Home/Filings/4/0001123292-19-000435

4//SEC Filing

Murray Mark J. 4

Accession 0001123292-19-000435

CIK 0001447028other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 6:07 PM ET

Size

5.4 KB

Accession

0001123292-19-000435

Insider Transaction Report

Form 4

Period: 2019-03-01

Arbutus Biopharma CorpABUS

DirectorPresident & CEO

Transactions

Award
Employee Stock Option (Right to Buy)
2019-03-01+357,500→ 357,500 total
Exercise: $4.57Exp: 2029-03-01→ Common Shares (357,500 underlying)

Footnotes (1)

[F1]The option will vest and become exercisable in three equal annual installments beginning March 1, 2020.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Arbutus Biopharma Corp

CIK 0001447028

Entity typeother

Related Parties

1

filerCIK 0001628383

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 6:07 PM ET
Size: 5.4 KB

View on SEC.gov